Pharmacological Treatment of Pain

  • Gisèle PickeringEmail author
Part of the Perspectives in Nursing Management and Care for Older Adults book series (PNMCOA)


Age-related factors influence the pharmacology of drugs and their efficacy/safety ratio. Pain treatment recommendations underline a more tailored approach. However, pain treatment in older persons with cognitive disorders, communication problems, or dementia is complex. This chapter reviews the challenges of adequate pain management in older persons.


Analgesics Antidepressants Antiepileptics Neuropathic pain 


  1. Abraham NS, El-Serag HB, Johnson ML. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. J Gastroenterol. 2005;129:1171–8.CrossRefGoogle Scholar
  2. ACR American College of Rheumatology Ad Hoc Group on Use of selective and non selective NSAI drugs. Recommendations for use: an American College of Rheumatology white paper. Arthritis Rheum. 2008;59:1058–73.CrossRefGoogle Scholar
  3. AGS American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331–46.CrossRefGoogle Scholar
  4. APS Australian Pain Society. Pain in residential aged care facilities management strategies; 2005.Google Scholar
  5. Arnstein RN. Balancing analgesic efficacy with safety concerns in the older patient. Pain Manag Nurs. 2010;11:S11–22.CrossRefPubMedGoogle Scholar
  6. Ballard C, Corbett A. Agitation and aggression in people with Alzheimer’s disease. Curr Opin Psychiatry. 2013;26(3):252–9.CrossRefPubMedGoogle Scholar
  7. Baraf HS, Gloth FM, Barthel HR, et al. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicenter trials. Drugs Aging. 2011;28:27–40.CrossRefPubMedGoogle Scholar
  8. British Pain Society. The assessment of pain in older people. Concise guidance to good practice. A series of evidence-based guidelines for clinical management. Number 8. National guidelines; 2007.Google Scholar
  9. Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. Clin Pharmacokinet. 2008;47:297–321.CrossRefGoogle Scholar
  10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.CrossRefPubMedGoogle Scholar
  11. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24.CrossRefPubMedGoogle Scholar
  12. Gloth FM III. Pharmacological management of persistent pain in older persons: focus on opioids and nonopioids. J Pain. 2011;1(Supp l):S14–20.CrossRefGoogle Scholar
  13. Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokin. 2000;38:271–90.CrossRefGoogle Scholar
  14. Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokin. 1998;35:49–64.CrossRefGoogle Scholar
  15. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.CrossRefPubMedGoogle Scholar
  16. Hegeman J, van den Bemt BJ, Duyses J, van Limbeek J. NSAIDs and the risk of accidental falls in the elderly: a systematic review. Drug Saf. 2009;32:489–98.CrossRefPubMedGoogle Scholar
  17. Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:d4065.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009;26(6):483–92.CrossRefPubMedGoogle Scholar
  19. Kinirons MT, Crome P. Clinical pharmacokinetics considerations in the elderly: an update. Clin Pharmacokin. 1997;33:302–12.CrossRefGoogle Scholar
  20. Kverno KS, Rabins PV, Blass DM, Hicks KL, Black BS. Prevalence and treatment of neuropsychiatric symptoms in advanced dementia. J Gerontol Nurs. 2008;34(12):8–15.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30–9.CrossRefPubMedGoogle Scholar
  22. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev. 2007;18(2):CD005594.Google Scholar
  23. Lussier D, Pickering G. Pharmacology considerations in older patients. In: Baulieu, et al., editors. Pharmacology of pain. Seattle: IASP Press; 2010. p. 547–67.Google Scholar
  24. Maclullich AM, Anand A, Davis DH, Jackson T, Barugh AJ, Hall RJ, Ferguson KJ, Meagher DJ, Cunningham C. New horizons in the pathogenesis, assessment and management of delirium. Age Ageing. 2013;42(6):667–74.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Manchikanti L, Helm S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15:ES9–ES38.PubMedGoogle Scholar
  26. McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol. 2011;71:351–64.CrossRefPubMedPubMedCentralGoogle Scholar
  27. Natusch D. Equianalgesic doses of opioids – their use in clinical practice. Br J Pain. 2012;6(1):43–6.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Nolan L, O’Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;32:142–9.CrossRefGoogle Scholar
  29. Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, Abu-Hanna A. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One. 2012;7(8):e43617.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Paolisso G, Gambardella A, Balbi V, Ammendola S, D’Amore A, Varrichio M. Body composition, body fat distribution, and resting metabolic rate in healthy centenarians. Am J Clin Nutr. 1995;62:746–50.CrossRefPubMedGoogle Scholar
  31. Parsons C. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem. Ther Adv Drug Saf. 2017;8(1):31–46.CrossRefPubMedGoogle Scholar
  32. Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8:287–313.CrossRefPubMedGoogle Scholar
  33. Pickering G. Frail elderly, nutritional status and drugs. Arch Gerontol Geriatr. 2004;38:174–80.CrossRefPubMedGoogle Scholar
  34. Pickering G. Analgesic use in the older person. Curr Opin Support Palliat Care. 2012;6:207–12.CrossRefPubMedGoogle Scholar
  35. Pickering G. Antiepileptics for post-herpetic neuralgia: current and future prospects. Drugs Aging. 2014;31(9):653–60.CrossRefPubMedGoogle Scholar
  36. Pickering G, Schneider E, Papet I, et al. Acetaminophen metabolism after major surgery: a bigger challenge with increasing age. Clin Pharmacol Ther. 2011;90:707–11.CrossRefPubMedGoogle Scholar
  37. Pickering G, Pereira B, Clère F, Sorel M, de Montgazon G, Navez M, Picard P, Roux D, Morel V, Salimani R, Adda M, Legout V, Dubray C. Cognitive function in older patients with postherpetic neuralgia. Pain Pract. 2014;14(1):E1–7.CrossRefPubMedGoogle Scholar
  38. Pickering G, Martin E, Tiberghien F, Delorme C, Mick G. Localized neuropathic pain: an expert consensus on local treatments. Drug Des Devel Ther. 2017;11:2709–18. Scholar
  39. Pujos-Guillot E, Pickering G, Lyan B, et al. Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids. Age (Dordr). 2012;34:181–93.CrossRefGoogle Scholar
  40. Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging. 2001;18:837–51.CrossRefPubMedGoogle Scholar
  41. Schulze J, Glaeske G, van den Bussche H, Kaduszkiewicz H, Koller D, Wiese B, Hoffmann F. Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf. 2013;22(12):1308–16.CrossRefPubMedGoogle Scholar
  42. Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic tables: are they all equally dangerous? J Pain Symptom Manag. 2009;38(3):409–17.CrossRefGoogle Scholar
  43. Shi S, Mörike K, Klotz U. The clinical implications of aging for rational drug therapy. Eur J Clin Pharmacol. 2008;64:183–99.CrossRefPubMedGoogle Scholar
  44. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293(5):596–608.CrossRefPubMedGoogle Scholar
  45. Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010;170:1979–86.CrossRefPubMedGoogle Scholar
  46. Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2012;170:1968–78.CrossRefGoogle Scholar
  47. Syrmis W, Good P, Wootton J, Spurling G. Opioid conversion ratios used in palliative care: is there an Australian consensus? Intern Med J. 2014;44(5):483–9.CrossRefPubMedGoogle Scholar
  48. Tumer N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol. 1992;32:271–302.CrossRefPubMedGoogle Scholar
  49. Van Leen MWF, Van Der Eijk I, Schols JMGA. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes. Age Ageing. 2007;36:414–8.CrossRefPubMedGoogle Scholar
  50. Visser LE, Graatsma HH, Tricker BHC. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol. 2002;53:183–8.CrossRefPubMedPubMedCentralGoogle Scholar
  51. Zhang W, Doherty M, Arden N, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669–81.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Clinical PharmacologyUniversity Regional HospitalClermont-FerrandFrance
  2. 2.Inserm CIC1405 and Neurodol 1107, Medical FacultyUniversity Clermont AuvergneClermont-FerrandFrance

Personalised recommendations